Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block

Circulation

Volumn 91, Issue 3, 1995, Pages 864-872

  Vos, Marc A ^a   Verduyn, S Cora ^a   Gorgels, Anton P M ^a   Lipcsei, Gyorgyi C ^a   Wellens, Hein J J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

electric stimulation; magnesium; tachycardia

Indexed keywords

ISOPRENALINE; SOTALOL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DOG; DRUG EFFICACY; FEMALE; HEART DEPOLARIZATION; HEART PACING; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; REPRODUCIBILITY; TORSADE DES POINTES;

EID: 0028890324     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.3.864     Document Type: Article

References (29)

1. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT-syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988; 31:115-172.
2. El-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia dependent early after-depolarizations. Circ Res. 1988; 63:286-305.
3. Ben David J, Zipes DP. Differential response to right and left ansae subclaviae stimulation of early afterdepolarizations and ventricular tachycardia induced by cesium in dogs. Circulation. 1988;78: 1241-1250.
4. Patterson E, Szabo B, Scherlag BJ, Lazzara R. Early and delayed afterdepolarizations associated with cesium chloride induced arrhythmias in the dog. J Cardiovasc Pharmacol. 1990;15:323-331.
5. Hanich RF, Levine JH, Spear JF, Moore EN. Autonomic modulation of ventricular arrhythmia in cesium chloride induced long QT syndrome. Circulation. 1988;77:1149-1161.
6. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Circulation. 1983;68:846-856.
7. Nayebpour M, Solymoss BC, Nattel S. Cardiovascular and metabolic effects of caesium chloride injection in dogs: limitations as a model for the long QT syndrome. Cardiovasc Res. 1989;23:756-766.
8. Bardy GH, Ungerleider RM, Smith WM, Ideker RE. A mechanism of torsade de pointes in a canine model. Circulation. 1983;67:52-59.
9. Leichter D, Danilo P Jr, Boyden P, Rosen TS, Rosen MR. A canine model of torsade de pointes. PACE. 1988;11:2235-2245.
10. Weissenburger J, Chezalviel F, Davy JM, Lainee P, Guhennec C, Penin E, Engel F, Cynober L, Motte G, Cheymol G. Methods and limitations of an experimental model of long QT syndrome. J Pharmacol Meth. 1991;26:23-42.
11. Steiner CH, Kovalik ATHW. A simple technique for production of chronic complete heart block in dogs. J Appl Physiol. 1968;25: 631-632.
12. Steld AVD, Dassen W, Gorgels APM, Beekman HDM, Wellens HJJ. Flexible multiprocessor system to support electrophysiological investigation in animals. Comput Cardiol. 1984;11:525-528.
13. Franz MR, Chin MC, Sharkey HR, Griffin JC, Scheinmann MM. A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo. J Am Coll Cardiol. 1990;16:878-886.
14. Bazett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353-368.
15. Carlsson L, Abrahamsson C, Drews L, Duker G. Anti-arrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation. 1992;85:1491-1500.
16. Fish FA, Prahesh C, Roden DM. Suppression of repolarization-related arrhythmias in vitro and in vivo by low dose potassium channel activators. Circulation. 1990;82:1362-1369.
17. Vos MA, Gorgels AOM, Lipcsei GE, de Groot SHM, Leunissen HDM, Wellens HJJ. Mechanism specific anti-arrhythmic effects of the potassium channel activator Levcrokalim against repolarization dependent tachycardias. J Cardiovasc Electrophysiol. 1994;5: 731-742.
18. Bardy DS, Inoue H, Kaseda S, Ben-David J, Zipes DP. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation. 1988;77: 1395-1402.
19. Buchanan LV, Kabell G, Branden MN, Gibson JK. Comparative assessment of ibutilide, d-sotalol, clofilium, E-4031 and UK-68,798 in a rabbit model of pro-arrhythmia. J Cardiovasc Pharmacol. 1993; 220:540-549.
20. Antonaccio MJ, Gomoll AW. Sotalol: pharmacological and anti-arrhythmic effects. Cardiovasc Drug Rev. 1988;6:239-263.
21. Strauss HC, Bigger JT, Hoffman BF. Electrophysiological and beta receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970;24:661-671.
22. Hondeghem LM, Snijders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go. Circulation. 1990;81:686-690.
23. Duker G, Almgren O, Carlsson L. Electrophysiologic and hemodynamic effects of H234/09 (Almokalant), quinidine and d-sotalol in the anaesthetized dog. J Cardiovasc Pharmacol. 1992;20:458-465.
24. Mortensen E, Yang T, Refsum H. Class III anti-arrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs. J Cardiovasc Pharmacol. 1992;19:216-221.
25. Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. Torsade de pointes: the long-short initiating sequence and other clinical features. J Am Coll Cardiol. 1983;2:806-817.
26. Evans ER, Curry PVL, Fitchett DH, Krikler DM. Torsade de pointes initiated by electrical ventricular stimulation. J Electrocardiol. 1976;9:255-258.
27. Horowitz L, Greenspan AM, Spielman SR, Josephson ME. Torsade de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation. 1981;63:1120-1128.
28. Atwell D, Lee JA. A cellular basis for the primary long QT syndromes. Lancet. 1988;1:1136-1139.
29. 4. Circulation. 1992;86(suppl I):I-560. Abstract.